Skip to main content
;

INST Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
MINUTES OF PROCEEDINGS
 
Meeting No. 4
 
Thursday, February 26, 2004
 

The Standing Committee on Industry, Science and Technology met in a televised session at 9:31 a.m. this day, in Room 253-D Centre Block, the Chair, Brent St. Denis, presiding.

 

Members of the Committee present: Paul Crête, Hon. Joe Fontana, Cheryl Gallant, Hon. Gurbax Malhi, Grant McNally, James Rajotte, Carol Skelton, Brent St. Denis and Hon. Lyle Vanclief.

 

Acting Members present: Alexa McDonough for Brian Masse, Réal Ménard for Jocelyne Girard-Bujold and Paddy Torsney for Marlene Jennings.

 

In attendance: Library of Parliament: Lalita Acharya, Analyst; Dan Shaw, Analyst; Kristen Douglas, Analyst.

 

Witnesses: Canada's Research-Based Pharmaceutical Companies (Rx&D): Jean-François Leprince, President, Aventis Pharma; Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc. Canadian Generic Pharmaceutical Association: Jim Keon, President; David Windross, Vice-President, Government and Professional Affairs, Novopharm Limited. Doctors Without Borders: Rachel Kiddell-Monroe, Coordinator (Canada) Access to Essential Medicines Campaign; Virginia Gularte, Medical Doctor, MSF Guatemala. Oxfam Canada: Mark Fried, Communications and Advocacy Coordinator. Canadian HIV/AIDS Legal Network: Richard Elliott, Director, Policy and Legal Research. Interagency Coalition on AIDS and Development: Michael O'Connor, Executive Director. CARE Canada: Michelle Munro, Policy and Programs Advisor, HIV/AIDS and Health.

 
Pursuant to the Order of Reference of Thursday, February 12, 2004, the Committee resumed consideration of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act.
 

The witnesses made statements and answered questions.

 

At 11:04 a.m., the sitting was suspended.

At 11:10 a.m., the sitting resumed.

 

The witnesses made statements and answered questions.

 

At 12:33 p.m., the Committee adjourned to the call of the Chair.

 



Louise M. Thibault
Clerk of the Committee

 
 
2004/03/01 2:32 p.m.